Stage Ia-IIa cancer of the cervix

Cancer Journal

Volumn 9, Issue 5, 2003, Pages 395-403

  Schilder, Jeanne M ^a,b   Stehman, Frederick B ^a,b  

^a Indiana University School of Medicine ^*

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; Early stage; Stage Ia IIa

Indexed keywords

CANCER RISK; CANCER STAGING; COMORBIDITY; DOCTOR PATIENT RELATION; HUMAN; PHYSICIAN; PRIORITY JOURNAL; RADIATION; REVIEW; SURGICAL APPROACH; UTERINE CERVIX CANCER; CLINICAL TRIAL; DECISION MAKING; FEMALE; PATHOLOGY; UTERINE CERVIX TUMOR;

CLINICAL TRIALS; DECISION MAKING; FEMALE; HUMANS; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 1542439970     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200309000-00010     Document Type: Review

References (67)

1. Jemal A, Murray T, Samuels A et al. Cancer statistics, 2003. Cancer J Clin 2003;53:5-26.
2. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157.
3. Sedlis A, Sall S, Tsukada Y et al. Microinvasive carcinoma of the uterine cervix: a clinical-pathologic study. Am J Obstet Gynecol 1979;133:64.
4. Ōstōr AG, Rome RM. Microinvasive squamous cell carcinoma of the cervix: a clinicopathologic study of 200 cases with long-term follow-up. Int J Gynecol Cancer 1994;4:257.
5. Creasman WT, Parker RT. Microinvasive carcinoma of the cervix. Clin Obstet Gynecol 1973;16:261-275.
6. Morris M, Mitchell MF, Silva EG et al. Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol 1993;51:193.
7. Van Nagell JR, Greenvvell N, Powell DF et al. Microinvasive carcinoma of the cervix. Am J Obstet Gynecol 1983;145:981.
8. Benedet J, Odicino F, Maisonneuve P et al. Carcinoma of the cervix uteri. J Epidemiol Biostat 1998;3:5-34.
9. Photopulos GJ, Vander Zwagg R. Class II radical hysterectomy shows less morbidity and good treatment efficacy compared to class III. Gynecol Oncol 1994;40:21.
10. Morley GW, Seski JC. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive microinvasion). Am J Obstet Gynecol 1976;126:785.
11. Landoni F, Maneo A, Colombo A et al. Randomized study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer. Lancet 1997;350:535.
12. Whitney CW, Stehman FB. The abandoned radical hysterectomy: a gynecologic oncology group study. Gynecol Oncol 2000;79:350-356.
13. Brewster WR, Monk BJ, Ziogas A et al. Intent-to-treat analysis of stage Ib and Iia cervical cancer in the United States: radiotherapy or surgery 1988-1995. Obstet Gynecol 2002;97:248-254.
14. Fletcher GH. Cancer of the uterine cervix: Janeway lecture, 1970. Am J Roentgenol Radium Ther Nucl Med 1971;111:225-242.
15. Gallion H, Van Nagell J, Donaldson ES et al. Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer 1985;56:262-265.
16. Jampolis S, Andras EJ, Fletcher GH. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology 1975;115:681-685.
17. Maruyama Y, Van Nagell J, Yoneda J et al. Dose-response and failure pattern for bulky or barrel-shaped stage IB cervical cancer treated by combined photon irradiation and extrafascial hysterectomy. Cancer 1989;63:70-76.
18. Nelson AJ III, Fletcher GH, Wharton JT. Indications for adjunctive conservative extrafascial hysterectomy in selected cases of carcinoma of the uterine cervix. Am J Roent Rad Ther Nue Med 1975;123:91-99.
19. O'Quinn AG, Fletcher GH, Wharton JT. Guidelines for conservative hysterectomy after irradiation. Gynecol Oncol 1980;9:68-79.
20. Rutledge FN, Wharton JT, Fletcher GH. Clinical studies with adjunctive surgery and irradiation therapy in the treatment of carcinoma of the cervix. Cancer 1976;38:596-602.
21. Thoms WW Jr., Eifel PJ, Smith TL et al. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 1992;23:491-499.
22. Grimard L, Genest P, Girard A et al. Prognostic significance of endometrial extension in carcinoma of the cervix. Gynecol Oncol 1988;31:301.
23. Perez CA, Grigsby PW, Camel HM et al. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of the uterine cervix: update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 1995;31:703-716.
24. Russell AH, Burt AR, Ek M et al. Adjunctive hysterectomy following radiation therapy for bulky carcinoma of the uterine cervix: prognostic implication of tumor persistence. Gynecol Oncol 1987;28:220.
25. Keys H, Bundy B, Stehman F et al. Adjuvant hysterectomy after radiation therapy reduces detection of local recurrence in "bulky" stage IB cervical without improving survival: results of a prospective randomized GOG trial [abstract]. Cancer J Sci Am 1997;3:117.
26. Delgado G. Stage IB squamous cancer of the cervix: the choice of treatment. Obstet Gynecol Surv 1978;33:174-183.
27. Delgado G, Bundy B, Zaino R et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352.
28. Finan MA, DeCasare S, Fiorica JV et al. Radical hysterectomy for stage Ib1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecol Oncol 1996;62:139-147.
29. Piver MS, Marchetti DL, Patton T et al. Radical hysterectomy and pelvic lymphadenopathy versus radiation therapy for small (3 cm) stage IB cervical carcinoma. Am J Clin Oncol 1988;11:21.
30. Sedlis A, Bundy BN, Rotman MZ et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol 1999;73:177.
31. National Cancer Institute: Concurrent chemoradiation for cervical cancer. Clinical Announcement. February 22, 1999, Washington, DC: National Cancer Institute.
32. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161.
33. Peters WA III, Liu PY, Barrett R et al. Cisplatin, 5-flurouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase III inter-group study [abstract]. Gynecol Oncol 1999;72:443.
34. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143.
35. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153.
36. Whitney CW, Sause W, Bundy BN et al. A randomized comparison of fluorouracil plus cisplalin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-1348.
37. Protocol GOG-0201: Treatment of patients with stage IB2 carcinoma of the cervix: a randomized comparison of radical hysterectomy and tailored chemo-radiation versus primary chemoradiation. September 12, 2002.
38. Dottino P, Plaxe S, Beddoe A et al. Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 1991;40:7.
39. Kim D, Moon H, Hwang Y et al. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage IB, IIA, and IIB with bulky tumor. Gynecol Oncol 1988;29:321.
40. Park T, Choi D, Kim S et al. Role of induction chemotherapy in invasive cervical cancer. Gynecol Oncol 1991;41:107.
41. Rabinovich M, Focaccia G, Ferreyra R et al. Neoadjuvant chemotherapy for cervical carcinoma. Obstet Gynecol 1991;78:685.
42. Tattersall M, Ramirez C, Coppleson M. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage IBIIA cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol 1992;46:176.
43. Benedetti-Panici P, Landoni F, Greggi S et al. Neoadjuvant chemotherapy and radical surgery vs exclusive radiotherapy in locally advanced squamous cell cervical cancer (LASCCC): results from the Italian Multicenter Randomized Study. Proc Am Soc Clin Oncol 1999;18:357a.
44. Chang TC, Lai CH, Hsueh S et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin and radical hysterectomy versus radiation therapy for bulky IB and IIA cervical cancer. Proc Am Soc Clin Oncol 1999;18:365a.
45. Eifel PJ, Morris M, Wharton JT et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994;29:9-16.
46. Sevin BU, Nadji M, Lampe B et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 1995;76[10 suppl]:1978-1986.
47. Stehman FB, Bundy BN, DiSaia PJ et al. Carcinoma of the cervix treated with radiation therapy I: a multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991;67:2776-2785.
48. Trattner M, Graf AH, Lax S et al. Prognostic factors in surgically treated stage IB-IIB cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol 2001;82:11-16.
49. Van Nagell JR Jr, Rayburn W, Donaldson ES et al. Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer 1979;44:2354.
50. Perez CA, Grigsby PW, Nene SM et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992;69:2796.
51. Delgado G, Bundy BN, Fowler WC et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1989;35:314.
52. Roman LD, Felix JC, Muderspach LI et al. Influence of lymphvascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol 1998;68:220-225.
53. Delgado G. Lymphovascular space involvement in cervical cancer: an independent risk factor. Gynecol Oncol 1998;68:219.
54. Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients irradiated post-operatively for carcinoma of the uterine cervix. Acta Radiol 1984;23:455.
55. Tinga DJ, Timmer PR, Bouma J et al. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol 1990;39:175.
56. Orr JW, Ball GC, Soong SJ et al. Surgical treatment of women found to have invasive cervix cancer at the time of total hysterectomy. Obstet Gynecol 1986;63:353.
57. Perez CA. Uterine cervix: principles and practice of radiation oncology 1998:1733.
58. Estape RE, Angioli R, Madrigal M et al. Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol Oncol 1998;68:229-232.
59. Berek JS, Castaldo TW, Hacker NF et al. Adenocardnoma of the uterine cervix. Cancer 1981;48:2734.
60. Eifel PJ, Morris M, Oswald MJ et al. Adenocarcinoma of the uterine cervix: prognosis and patterns of failure in 367 cases treated at the M.D. Anderson Cancer Center between 1965 and 1985. Cancer 1990;65:2507.
61. Eifel PJ, Burke TW, Delclos L et al. Early stage 1 adenocarcinoma of the uterine cervix: treatment results in patients with tumors S 4 cm in diameter. Gynecol Oncol 1991;41:199-205.
62. Rutledge FN, Gutierrez AG, Fletcher GH. Management of stage I and II adenocarcinomas of the uterine cervix on intact uterus. Am J Roent Rad Ther Nucl Med 1968;102:161-164.
63. Rutledge FN, Galakatos AE, Wharton JT et al. Adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 1975;122:236-245.
64. Look KY, Brunetto VL, Clarke-Pearson D et al. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1996;63:304-311.
65. Sutton GP, Bundy BN, Delgado G et al. Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1992;166:50-53.
66. Brown JV, Fu YS, Berek JS. Ovarian metastases are rare in stage I adenocarcinoma of the cervix. Obstet Gynecol 1990;76:623-626.
67. Kinney WK, Webb MJ, Hodge DO et al. Ovarian preservation and risk of recurrence following radical hysterectomy for stage IB cancer of the cervix [abstract]. Society of Gynecologic Oncologists Annual Meeting, Nashville, TN, March 3-7, 2001.